Health Condition 1: null- Patients With Mild To Moderate Psoriasis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients clinically diagnosed with mild to moderate psoriasis. 2)Patients having PASI 3 % to 20 % and PGA - mild to moderate grade
Exclusion criteria
Exclusion criteria: 1)Patients having sever psoriasis (PASI >20 % and PGA â?? severe grade) 2)Other inflammatory skin disease in the treatment area that may confound the evaluation of the psoriasis (e.g., atopic dermatitis, contact dermatitis, tinea corporis) 3)Current or past history of hypercalcemia, renal insufficiency, or hepatic disorders. 4)Patients on medication with drugs that can aggravate psoriasis like beta blockers, calcium channel blockers, or lithium. 5)Patients with any superadded infected psoriasis. 6)Pregnant or nursing (lactating) women. 7)Subject is taking or requires corticosteroids. 8)History or evidence of drug or alcohol abuse. 9)Unwilling or unable to comply with the requirements of this protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psoriasis area and severity index score(PASI)Timepoint: 03 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Physicianâ??s static Global Assessment (sPGA) 2)Nail psoriasis index score (NAPSI) 3)Dermatology Life Quality Index (DLQI) 4)Visual analogue scale (VAS) 5)By the coloured photographs which will be taken before & after treatment (with the same magnification). Timepoint: 03 months | — |
Countries
India
Contacts
National Institute Of Unani Medicicne